Ghost Tree Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

Ghost Tree Capital’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$8.66M	Buy	450,000 +100,000	+29%	+$2.07M	2.62%	13
2024 Q2	$7.19M	Buy	350,000 +200,000	+133%	+$4.19M	2.25%	17
2024 Q1	$3.57M	Buy	+150,000	New	+$3.35M	0.99%	34
2023 Q4	–	Sell	-200,000	Closed	-$2.9M	–	71
2023 Q3	$2.9M	Sell	200,000 -150,000	-43%	-$2.84M	0.96%	35
2023 Q2	$7.33M	Buy	350,000 +25,000	+8%	+$520K	2.42%	15
2023 Q1	$6.86M	Buy	325,000 +175,000	+117%	+$4.35M	2.03%	20
2022 Q4	$3.82M	Sell	150,000 -50,000	-25%	-$1.17M	1.63%	23
2022 Q3	$4.81M	Sell	200,000 -25,000	-11%	-$561K	1.35%	27
2022 Q2	$4.33M	Hold	225,000	–	–	2.25%	20
2022 Q1	$3.91M	Sell	225,000 -75,000	-25%	-$1.26M	0.85%	22
2021 Q4	$6.57M	Sell	300,000 -275,000	-48%	-$5.08M	2.35%	15
2021 Q3	$11M	Sell	575,000 -300,000	-34%	-$5M	3.21%	9
2021 Q2	$15M	Sell	875,000 -300,000	-26%	-$5.49M	4.13%	7
2021 Q1	$26.3M	Sell	1,175,000 -175,000	-13%	-$3.95M	6.18%	2
2020 Q4	$30M	Buy	1,350,000 +925,000	+218%	+$19.2M	6.69%	2
2020 Q3	$6.27M	Buy	425,000 +240,000	+130%	+$3.66M	1.81%	19
2020 Q2	$2.74M	Sell	185,000 -65,000	-26%	-$990K	0.72%	36
2020 Q1	$2.74M	Buy	+250,000	New	+$2.35M	0.73%	30
2017 Q3	–	Sell	-200,000	Closed	-$2.79M	–	73
2017 Q2	$2.79M	Buy	+200,000	New	+$2.29M	0.58%	55

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ghost Tree Capital's SNDX Position: Q3 2024 in Review

Ghost Tree Capital increased its Syndax Pharmaceuticals (SNDX) stake by 29% in Q3 2024, buying an estimated $2.07M and bringing the position to 450,000 shares worth $8.66M. The position accounts for 2.62% of the portfolio, ranked #13.

Ghost Tree Capital first reported a position in SNDX in Q2 2017 and has held it in 19 quarters since. The position peaked at $30M in Q4 2020. 210 funds tracked by Wall St. Rank hold SNDX as of Q3 2024.

Ghost Tree Capital held 450,000 shares of Syndax Pharmaceuticals worth $8.66M as of Q3 2024.
Ghost Tree Capital bought 100,000 Syndax Pharmaceuticals shares in Q3 2024, an estimated $2.07M.
Syndax Pharmaceuticals made up 2.62% of Ghost Tree Capital's portfolio in Q3 2024, its #13 holding.
Ghost Tree Capital first reported a position in Syndax Pharmaceuticals in Q2 2017 and has held it in 19 quarters since.
Ghost Tree Capital's Syndax Pharmaceuticals position peaked at $30M in Q4 2020.
210 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.